In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Teva and Barr Announce Launch of Generic Allegra® Tablets by Teva Under Agreement With Barr
BioSeek and UCB Establish New Compound Evaluation Collaboration, Expand Previous Agreement
Alpharma and Teva Enter Into Agreement Relating to Gabapentin
Crucell and DSM Biologics announce PER.C6® licensing agreement with UCB
Eisai and Teva mutually agree to end collaboration agreement for Rasagiline
Otsuka and UCB agreed to co-develop and co-promote Keppra® and Cimzia® in Japan
Otsuka and UCB agreed to co-develop and co-promote Keppra® and Cimzia® in Japan